Nicholas Ostrout

Senior Director, Commercial Strategy and Implementation  • Lonza Ltd

Dr. Nicholas Ostrout leads the commercial development team for the Personalized Medicine Business Unit at Lonza. Dr. Ostrout earned his PhD in Immunology from Case Western Reserve University and has been working in sales, marketing, and business development for most of his career. Nicholas most recently came from Miltenyi Biosciences. Dr. Ostrout is primarily focused on launching the Cocoon Platform into the market and scaling out manufacturing capabilities for cell and gene therapies with the Cocoon both internally within Lonza and with external partners. Nick’s primary goal, as part of Lonza’s PerMed team, is to make these lifesaving cell therapies at a lower cost, and on a higher scale, in order to be able to treat as many patients as possible.

Also Speaking

Daniel Teasley

Head of Viral & Gene Therapy Products and Services • MilliporeSigma

Emily English

Director of Quality • Cartesian Therapeutics

Matthew Lakelin

Vice President, Business Development and Scientific Affairs • TrakCel

Event Info


Fun Run